Guardian Pharmacy Services reported revenue of $351.77M and net income of $22.12M for the quarter ended Jun 2026, up 2.2% year over year. This income statement covers 12 quarters of results from Sep 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||
| Revenue | 262.74M | 281.07M | 275.41M | 300.04M | 314.39M | 338.57M | 329.31M | 344.33M | 377.43M | 397.62M | 336.60M | 351.77M |
| Cost of RevenueCost of Rev | 210.55M | 226.49M | 220.31M | 238.75M | 253.51M | 271.46M | 264.96M | 276.19M | 302.71M | 312.11M | 260.29M | 271.72M |
| Gross Profit | 52.19M | 54.58M | 55.10M | 61.29M | 60.88M | 67.10M | 64.35M | 68.15M | 74.72M | 85.50M | 76.31M | 80.04M |
| Operating items | ||||||||||||
| Selling, General & AdministrativeSG&A | 58.52M | 39.05M | 47.17M | 44.28M | 165.49M | 50.35M | 51.34M | 55.57M | 58.37M | 54.74M | 58.63M | 59.40M |
| Operating ExpensesOpex | 58.52M | 39.05M | 47.17M | 44.28M | 165.49M | 50.35M | 51.34M | 55.57M | 58.37M | 54.74M | 58.63M | 59.40M |
| Operating IncomeOp. Inc | -6.33M | 15.52M | 7.93M | 17.00M | -104.61M | 16.75M | 13.01M | 12.58M | 16.35M | 30.76M | 17.68M | 20.64M |
| EBIT | -6.33M | 15.52M | 7.93M | 17.00M | -104.61M | 16.75M | 13.01M | 12.58M | 16.35M | 30.76M | 17.68M | 20.64M |
| Non-operating items | ||||||||||||
| Non Operating Interest Expenses | 0.72M | 0.74M | 0.77M | 1.07M | 1.03M | 0.42M | 0.17M | 0.17M | 0.16M | 0.16M | 0.15M | 0.15M |
| Other Non Operating IncomeOther Non Op Inc. | 0.05M | -0.23M | -0.07M | -0.09M | -0.00M | -0.11M | 0.27M | 0.18M | 0.44M | 0.50M | 0.77M | 9.30M |
| Non Operating IncomeNon Op. Inc. | -0.67M | -0.96M | -0.84M | -1.16M | -1.03M | -0.53M | 0.10M | 0.01M | 0.28M | 0.34M | 0.62M | 9.15M |
| Net income details | ||||||||||||
| EBT | -7.00M | 14.56M | 7.09M | 15.85M | -105.64M | 16.22M | 13.11M | 12.59M | 16.63M | 31.10M | 18.29M | 29.79M |
| Tax ProvisionsTaxes | 0.18M | 4.38M | 3.83M | 3.76M | 7.04M | 9.83M | 4.75M | 7.67M | ||||
| Profit After TaxPAT | -7.00M | 14.56M | 7.09M | 15.85M | -121.99M | 11.94M | 9.45M | 9.03M | 9.82M | 20.92M | 13.29M | 22.12M |
| Income from Non-Controlling InterestsInc. Minority | 4.29M | 2.54M | 4.31M | 5.22M | 6.82M | -0.10M | -0.17M | -0.20M | -0.23M | 0.34M | 0.25M | 0.25M |
| Income from Continuing OperationsIncome (Continuing) | -7.00M | 14.56M | 7.09M | 15.85M | -105.82M | 11.84M | 9.27M | 8.83M | 9.59M | 21.27M | 13.54M | 22.12M |
| Consolidated Net IncomeConsol Net Inc. | -7.00M | 14.56M | 7.09M | 15.85M | -105.82M | 11.84M | 9.27M | 8.83M | 9.59M | 21.27M | 13.54M | 22.12M |
| Income towards Parent CompanyParent Net Inc | -7.00M | 14.56M | 7.09M | 15.85M | -105.82M | 11.84M | 9.27M | 8.83M | 9.59M | 21.27M | 13.54M | 22.12M |
| Net Income towards Common StockholdersNet Income | -7.00M | 14.56M | 7.09M | 15.85M | -105.82M | 11.84M | 9.27M | 8.83M | 9.59M | 21.27M | 13.54M | 22.12M |
| Additional items | ||||||||||||
| EPS (Basic) | -0.43 | 0.10 | 0.15 | 0.07 | 0.15 | 0.17 | 213.89 | 174.66 | ||||
| EPS (Diluted) | -0.43 | 0.10 | 0.15 | 0.07 | 0.15 | 0.34 | 212.65 | 346.53 | ||||
| Shares Outstanding | 244.57M | 124.01M | 62.04M | 124.09M | 62.12M | 124.77M | 0.06M | 0.13M | ||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 244.57M | 124.01M | 62.91M | 126.41M | 63.43M | 63.30M | 0.06M | 0.06M | ||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 244.57M | 124.01M | 62.04M | 124.09M | 62.12M | 124.77M | 0.06M | 0.13M | ||||
| EBITDA | -6.33M | 15.52M | 7.93M | 17.00M | -104.61M | 16.75M | 13.01M | 12.58M | 16.35M | 30.76M | 17.68M | 20.64M |
| Interest ExpensesInt Expense | 0.72M | 0.74M | 0.77M | 1.07M | 1.03M | 0.42M | 0.17M | 0.17M | 0.16M | 0.16M | 0.15M | 0.15M |
| Tax Rate | -0.17% | 27.00% | 29.25% | 29.87% | 42.32% | 31.62% | 25.96% | 25.75% |